Last checked at 24 Sep 2014 12:12
24 September 2014
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Annual Report and Accounts
The Annual Report and Accounts for the year ended 30 June 2014 are available on the Company's website in the Investor Relations section. They can be located at http://www.allergytherapeutics.com/uploads/consolidatedyearend2014.pdf.
The shareholders copy of the Annual Report and Accounts for the year end 30 June 2014 will be posted to shareholders in mid-October together with the Notice of the Annual General Meeting.
For further information
Allergy Therapeutics | +44 (0) 1903 845 820 |
Manuel Llobet, Chief Executive Officer Ian Postlethwaite, Finance Director | |
Peel Hunt LLP | +44 (0) 20 7418 8900 |
James Steel Clare Terlouw | |
FTI Consulting | +44 (0) 20 3727 1000 |
Simon Conway Victoria Foster Mitchell |
Notes to editors
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the current financial year of £42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging Markets.